FORMA Therapeutics is a biopharmaceutical company intended for the discovery, development, and commercialization of transformative medicines. It has two core product candidates for development: FT-4202 for the treatment of sickle cell disease, or SCD, and other hemoglobinopathies, and FT-7051 for the treatment of metastatic castration-resistant prostate cancer, or mCRPC.
Market capitalization (12-Aug-2020)
Closing stock price (12-Aug-2020)
FORMA Therapeutics has 944 Twitter Followers. The number of followers has increased 1.6% month over month and increased 4.1% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was FORMA Therapeutics founded?
FORMA Therapeutics was founded in 2008.
Who are FORMA Therapeutics key executives?
FORMA Therapeutics's key executives are Frank D. Lee, David Cook and Patrick Kelly.
How many employees does FORMA Therapeutics have?
FORMA Therapeutics has 77 employees.
Who are FORMA Therapeutics competitors?
Competitors of FORMA Therapeutics include Kura Oncology, MyoKardia and Alkahest.
Where is FORMA Therapeutics headquarters?
FORMA Therapeutics headquarters is located at 500 Arsenal St #100, Watertown.
Where are FORMA Therapeutics offices?
FORMA Therapeutics has an office in Watertown.
How many offices does FORMA Therapeutics have?
FORMA Therapeutics has 1 office.
Receive alerts for 300+ data fields across thousands of companies